Waters Corporation WAT

Healthcare · Diagnostics & Research · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value
$16.01B
Market Cap
$41.82B
Margin of Safety
-161.2%
Intrinsic / Market Ratio
0.38

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

2.27B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

40.08B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

5.69B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

16.01B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

16.01B USD

from the sum above

Market Cap

41.82B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

0.38×

the ratio the screener ranks by; Margin of Safety -161.2% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 2.27B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)7.19B USD
−②Net Debt Today4.92B USD
+③Growth Value0 USD
=Value2.27B USD

EPV of the Operations (NOPAT over WACC)

7.19B USD

Net debt today

-4.92B USD

Growth Value

0 USD

Value

2.27B USD

①EPV (earnings power value)

7.19B USD

②Net Debt Today

4.92B USD

③Growth Value

0 USD

Market value

Market Cap41.82B USD

Today's price times the shares.

Value vs market

Margin of Safety-1743.6%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 40.08B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE27.28B USD
+②Equity at Year 15, Today12.79B USD
=Value40.08B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

27.28B USD

②Equity at Year 15, Today

12.79B USD

Market value

Market Cap41.82B USD

Today's price times the shares.

Value vs market

Margin of Safety-4.4%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 5.69B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF5.42B USD
+②Invested Capital at Year 15, Today5.19B USD
−③Net Debt Today4.92B USD
=Value5.69B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

5.42B USD

②Invested Capital at Year 15, Today

5.19B USD

③Net Debt Today

4.92B USD

Market value

Market Cap41.82B USD

Today's price times the shares.

Value vs market

Margin of Safety-635.6%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 10.44%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 1.19×Market Risk Premium 6.00%= 11.66%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 112.36M USDPretax Income 755.63M USD= 14.87%

The tax the interest saves.

Interest Expense =EBIT 825.25M USD−Pretax Income 755.63M USD= 69.62M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 69.62M USDTotal Debt 5.46B USD×(1 − Tax Rate for WACC 14.87%)= 1.09%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 5.46B USDMarket Cap + Total Debt 41.82B USD + 5.46B USD= 11.55%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 88.45%×Cost of Equity 11.66%+Debt Weight 11.55%×Cost of Debt 1.09%= 10.44%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 24.78B USD − Total Liabilities 9.57B USD = Book Value Today 15.21B USD

Total Debt 5.46B USD − Cash and Short-Term Investments 539.54M USD = Net Debt Today 4.92B USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 166.0%at most 5%does not pass98,225,000 / 59,176,000
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets0.0%at least -10.0%passes(653.21M USD − 643.27M USD) ÷ 24.78B USD
Price to bookMarket Cap ÷ Book Value Today2.75×at most 3×passes41.82B USD ÷ 15.21B USD
Operating marginOperating Income ÷ Revenue25.4%above 10.0%passes803.39M USD ÷ 3.17B USD
Revenue growthRevenue ÷ Revenue a Year Before − 17.0%above 10.0%does not pass3.17B USD / 2.96B USD
Net cash(Cash − Total Debt) ÷ Market Cap-11.8%above -30%passes(539.54M USD − 5.46B USD) ÷ 41.82B USD
Operating efficiencyOperating Income ÷ Gross Profit42.8%above 25.0%passes803.39M USD ÷ 1.88B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

426 USD

Enterprise value

46.79B USD

market cap plus net debt

EV / EBITDA

32.19×

Price / book

2.75×

the provider's book

Price / earnings

107.46×

Return on equity

1.9%

the provider's, not the engine's

Profit margin

3.6%

Revenue growth

113.4%

Analyst target, mean

447 USD

Analysts

23

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

2.97B2.96B2.96B3.17B

Gross profit

1.73B1.76B1.76B1.88B

Operating income

884.08M818.49M838.76M803.39M

EBITDA

operating income before depreciation and amortisation

1.02B1.00B1.04B1.03B

Pretax income

838.68M736.98M755.62M755.63M

Net income

708.46M642.88M638.47M643.27M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

716.75M642.88M648.26M643.27M

R&D

176.37M175.12M183.21M195.91M
Balance sheet, year end

Total assets

3.28B4.63B4.56B5.08B

Total liabilities

2.78B3.48B2.73B2.52B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

504.99M1.15B1.83B2.56B

Total debt

1.67B2.44B1.70B1.49B

Cash and equivalents

481.01M395.47M325.68M588.42M

Net PP&E

fixed assets after depreciation

669.39M724.39M726.12M723.53M

Working capital

current assets less current liabilities

979.14M964.25M880.23M909.05M
Cash flow

Operating cash flow

612.27M603.41M762.89M653.21M

Capital expenditure

paid out, so below zero

-183.64M-160.79M-142.62M-112.86M

Depreciation and amortisation

130.55M166.07M192.02M206.44M

Free cash flow

operating cash flow plus capital expenditure

428.63M442.62M620.26M540.35M